文献速递颈动脉与弓上血管

颅外颈动脉粥样硬化与神经原纤维缠结积累增加相关

Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulation.
PubMed 文献 · J Vasc Surg · 2021-08-31

前瞻性纵向临床病理研究纳入AZSAND与遗体捐献项目,比较有颅外颈动脉粥样硬化病(ECAD,n=66)与无ECAD(n=125)者的尸检病理密度。ECAD与神经原纤维缠结(NFT)负荷增加21%相关(P=.02),在颞叶(P<.05)和内嗅皮层(P=.02)显著;接受颈动脉内膜剥脱术(CEA,n=32)者NFT密度低于未手术的ECAD者(n=66;P=.04)。ECAD与β-淀粉样斑块或脑淀粉样血管病(CAA)密度无关。

要点

  • ECAD与死亡时NFT负荷增加21%相关,颞叶和内嗅皮层显著。
  • CEA与ECAD患者NFT密度降低相关,提示治疗可能影响神经病理。
  • ECAD与β-淀粉样斑块或CAA密度无关。

核心结论

  • ECAD与颞叶和内嗅皮层的NFT负荷相关,对AD和非AD痴呆及认知功能障碍有临床意义。
  • 需进一步理解ECAD是否增加神经退行性脑改变风险,因ECAD是可治疗疾病且尚未作为痴呆风险因素被评估或专门治疗。

研究设计与样本

  • 前瞻性、纵向、临床病理研究,来自AZSAND和Brain and Body Donation Program。
  • 记录临床诊断ECAD的有无,并在死亡时进行NFT、β-淀粉样斑块和CAA的半定量密度评估。
  • 经logistic回归确定潜在混杂因素并调整后,比较ECAD组(n=66)与无ECAD组(n=125)的组织病理密度评分。

主要发现

  • ECAD与死亡时NFT负荷增加21%相关(P=.02)。
  • NFT负荷增加见于评估的整个脑区,但在颞叶(P<.05)和内嗅皮层(P=.02)显著。
  • 接受CEA的ECAD者(n=32)NFT密度低于未接受CEA的ECAD者(n=66;P=.04)。
  • ECAD与β-淀粉样斑块或CAA密度无关。

临床怎么用

  • ECAD患者评估认知功能时需关注痴呆风险,尤其颞叶和内嗅皮层相关认知域。
  • CEA可能对神经病理负荷有益,但需进一步研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to determine whether extracranial carotid atherosclerotic disease (ECAD) is associated with increased key neurodegenerative pathology such as neurofibrillary tangle (NFT), beta-amyloid plaque, or cerebral amyloid angiopathy (CAA) accumulation, findings associated with Alzheimer's disease (AD) and other dementias. METHODS: Our prospective, longitudinal, clinicopathologic study, the AZSAND (Arizona study of aging and neurodegenerative disorders) and Brain and Body Donation Program, recorded the presence or absence of clinically diagnosed ECAD and performed semiquantitative density estimates of NFT, beta-amyloid plaque, and CAA at death. After adjusting for potential confounding factors determined by logistic regression analysis, histopathology density scores were evaluated in individuals with ECAD (n = 66) and those without ECAD (n = 125). RESULTS: We found that the presence of ECAD was associated with a 21% greater NFT burden at death compared with no ECAD (P = .02). Anatomically, an increased NFT burden was seen throughout the brain regions evaluated but was significant in the temporal lobe (P < .05) and entorhinal cortex (P = .02). In addition, we found that subjects who had undergone carotid endarterectomy (CEA), the surgical treatment of ECAD (n = 32), had decreased NFT densities compared with those with ECAD who had not undergone CEA (n = 66; P = .04). In contrast to NFT, ECAD was not associated with beta-amyloid plaques or CAA density. CONCLUSIONS: These findings indicate that ECAD is associated with the NFT burden in the temporal lobe and entorhinal cortex, which has clinical significance for AD and non-AD dementias and cognitive dysfunction. Further understanding of whether ECAD increases the risk of neurodegenerative brain changes is highly relevant because ECAD is a treatable disease that has not, otherwise, been evaluated for nor specifically treated as a dementia risk factor.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Arias JC, Edwards M, Vitali F, et al. Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulation. J Vasc Surg. 2021. PMID: 34478810. doi:10.1016/j.jvs.2021.07.238

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。